Hologic (FRA:HO1) Additional Paid-In Capital : €5,702 Mil(As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Hologic Additional Paid-In Capital?

Hologic's quarterly additional paid-in capital declined from Sep. 2023 (€5,754 Mil) to Dec. 2023 (€5,556 Mil) but then increased from Dec. 2023 (€5,556 Mil) to Mar. 2024 (€5,702 Mil).

Hologic's annual additional paid-in capital increased from Sep. 2021 (€5,071 Mil) to Sep. 2022 (€6,103 Mil) but then declined from Sep. 2022 (€6,103 Mil) to Sep. 2023 (€5,754 Mil).

Hologic Additional Paid-In Capital Historical Data

The historical data trend for Hologic's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hologic Additional Paid-In Capital Chart

Hologic Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Additional Paid-In Capital

Get a 7-Day Free Trial

5,238.98

5,013.18

5,070.93

6,103.03

5,754.30

Hologic Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															5,689.46	5,651.07	5,754.30	5,555.83	5,701.79

Hologic Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Hologic Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Hologic's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Hologic (FRA:HO1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hologic Inc (FRA:HO1) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

HOLX:USA HOLX:Mexico HOLX:Austria

Address

250 Campus Drive, Marlborough, MA, USA, 01752

Website

http://www.hologic.com

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Hologic (FRA:HO1) Headlines

No Headlines